The Journal of Minimally Invasive Gynecology
Volume 17, Issue 5 , Pages 605-611 , September 2010

Human Amnion as a Temporary Biologic Barrier after Hysteroscopic Lysis of Severe Intrauterine Adhesions: Pilot Study

  • Mohamed I. Amer, MD

      Affiliations

    • Departments of Obstetrics and Gynecology, Ain Shams University, Cairo, Egypt
    • Corresponding Author InformationCorresponding author: Mohamed Ibrahim Mohamed Amer, MD, Department of Obstetrics and Gynecology, Ain Shams University, 169 Gisr El Suiz St, Bldg 5, Apt 51, Helliopolis, Cairo 11351 Egypt.
    • ,
  • Karim H.I. Abd-El-Maeboud, MD

      Affiliations

    • Departments of Obstetrics and Gynecology, Ain Shams University, Cairo, Egypt
    • ,
  • Ihab Abdelfatah, MD

      Affiliations

    • Departments of Obstetrics and Gynecology, Ain Shams University, Cairo, Egypt
    • ,
  • Fekrya Ahmad Salama, MD

      Affiliations

    • Departments of Obstetrics and Gynecology, Ain Shams University, Cairo, Egypt
    • ,
  • Al Said Abdallah, MB BCH

      Affiliations

    • Al Ismailia General Hospital, Ismailia, Egypt

Received 7 January 2010 ,Accepted 15 March 2010.

References 

  1. Klein SM, Garcia CR. Asherman's syndrome: a critique and current review. Fertil Steril. 1973;24:722–735
  2. Valle RF, Sciarra JJ. Intrauterine adhesions: hysteroscopic diagnosis, classification, treatment, and reproductive outcome. Am J Obstet Gynecol. 1988;158(6, pt 1):1459–1470
  3. March CM. Intrauterine adhesions. Obstet Gynecol Clin North Am. 1995;22:491–505
  4. Practice Committee of the American Society for Reproductive Medicine. Current evaluation of amenorrhea. Fertil Steril. 2006;86(5 suppl. 1):S148–S155
  5. Polishuk WZ, Sadovsky E. A syndrome of recurrent intrauterine adhesions. Am J Obstet Gynecol. 1975;123:151–158
  6. Schenker JG. Etiology of and therapeutic approach to synechia uteri. Eur J Obstet Gynecol Reprod Biol. 1996;65:109–113
  7. March CM, Israel R, March AD. Hysteroscopic management of intrauterine adhesions. Am J Obstet Gynecol. 1978;130:653–657
  8. Orhue AAE, Aziken ME, Igbefoh JO. A comparison of two adjunctive treatments for intrauterine adhesions following lysis. Int J Gynaecol Obstet. 2003;82:49–56
  9. Amer MI, El Nadim A, Hassanein K. The role of intrauterine balloon after operative hysteroscopy in the prevention of intrauterine adhesion: a prospective controlled study. MEFS J. 2005;10:125–129
  10. Guida M, Acunzo G, Di Spiezio Sardo A, et al. Auto-cross-linked hyaluronic acid gel after hysteroscopic surgery reduced formation of intrauterine adhesions. Evidence Based Obstet Gynecol. 2005;7:27–28
  11. Mohamed IA, Abd-El-Maeboud KH. Amnion graft following hysteroscopic lysis of intrauterine adhesions. J Obstet Gynaecol Res. 2006;32:559–566
  12. Subrahmanyam M. Amniotic membrane as a cover or microskin grafts. Br J Plast Surg. 1995;48:477–478
  13. Nakamura T, Yoshitani M, Rigby H, et al. Sterilized, freeze-dried amniotic membrane: a useful substrate for ocular surface reconstruction. Invest Ophthalmol Vis Sci. 2004;45:93–99
  14. Lee SH, Tseng SC. Amniotic membrane transplantation for persistent epithelial defects with ulceration. Am J Ophthalmol. 1997;123:303–312
  15. Chuck RS, Graff JM, Bryant MR, Sweet PM. Biomechanical characterization of human amniotic membrane preparations for ocular surface reconstruction. Ophthalmic Res. 2004;36:341–348
  16. Schenker JG, Margalioth EJ. Intrauterine adhesions: an update appraisal. Fertil Steril. 1982;37:593–610
  17. Pabuçcu R, Atay V, Orhon E, Urman B, Ergûn A. Hysteroscopic treatment of intrauterine adhesions is safe and effective in the restoration of normal menstruation and fertility. Fertil Steril. 1997;68:1141–1143
  18. Rochet Y, Dargent D, Bremond A, Priou G, Rudigoz RC. The obstetrical outcome of women with surgically treated uterine synechiae. [in French] J Gynecol Obstet Biol Reprod (Paris). 1979;8:723–726
  19. Polishuk WZ, Anteby SO, Weinstein D. Puerperal endometritis and intrauterine adhesions. Int Surg. 1975;60:418–420
  20. Fedele L, Bianchi S, Frontino G. Septums and synechiae: approaches to surgical correction. Clin Obstet Gynecol. 2006;49:767–788
  21. Protopapas A, Shushan A, Magos A. Myometrial scoring: a new technique for the management of severe Asherman's syndrome. Fertil Steril. 1998;69:860–864
  22. Duffy S, Reid PC, Smith JH, Sharp F. In vitro studies of uterine electrosurgery. Obstet Gynecol. 1991;78:213–220
  23. Roge P, D'Ercole C, Cravello L, Boubli L, Blanc B. Hysteroscopic management of uterine synechiae: a series of 102 observations. Eur J Obstet Gynecol Reprod Biol. 1996;65:189–193
  24. Kodaman PH, Arici A. Intrauterine adhesions and fertility outcome: how to optimize success?. Curr Opin Obstet Gynecol. 2007;19:207–214
  25. Morris H. Surgical pathology of the lower uterine segment cesarean section scar: is the scar a source of clinical symptoms?. Int J Gynecol Pathol. 1995;14:16–20
  26. Padykula HA. Regeneration in the primate uterus: the role of stem cells. Ann NY Acad Sci. 1991;622:47–56
  27. Okulicz WC. Regeneration. In:  Glasser SR,  Aplin JD,  Giudice LC,  Tabibzadeh S editor. The Endometrium. London, England: Taylor and Francis, Inc.; 2002;p. 110–120
  28. Alison MR, Poulsom R, Forbes S, Wright NA. An introduction to stem cells. J Pathol. 2002;197:419–423
  29. Fuchs E, Segre JA. Stem cells: a new lease on life. Cell. 2000;100:143–155
  30. Ilancheran S, Moodley Y, Manuelpillai U. Human fetal membranes: a source of stem cells for tissue regenerationand repair?. Placenta. 2009;30:2–10
  31. Samuel GN, Kerridge IH, O'Brien TA. Umbilical cord blood banking: public good or private benefit?. Med J Aust. 2008;188:533–535
  32. Yen BL, Huang HI, Chien CC, et al. Isolation of multipotent cells from human term placenta. Stem Cells. 2005;23:3–9
  33. Miki T, Strom SC. Amnion-derived pluripotent/multipotent stem cells. Stem Cell Rev. 2006;2:133–142
  34. Fauza D. Amniotic fluid and placental stem cells. Best Pract Res Clin Obstet Gynaecol. 2004;18:877–891
  35. Hori J, Wang M, Kamiya K, Takahashi H, Sakuragawa N. Immunological characteristics of amniotic epithelium. Cornea. 2006;25(10 suppl. 1):S53–S58
  36. Shimazaki J, Aiba M, Goto E, Kato N, Shimmura S, Tsubota K. Transplantation of human limbal epithelium cultivated on amniotic membrane for the treatment of severe ocular surface disorders. Ophthalmology. 2002;109:1285–1290
  37. Tseng SC, Li DQ, Ma X. Suppression of transforming growth factor-beta isoforms, TGF-beta receptor type II, and myofibroblast differentiation in cultured human corneal and limbal fibroblasts by amniotic membrane matrix. J Cell Physiol. 1999;179:325–335
  38. Kjaergaard N, Hein M, Hyttel L. Antibacterial properties of human amnion and chorion in vitro. Eur J Obstet Gynecol Reprod Biol. 2001;94:224–229
  39. Mencucci R, Menchini U, Dei R. Antimicrobial activity of antibiotic-treated amniotic membrane: an in vitro study. Cornea. 2006;25:428–431
  40. Stock SJ, Kelly RW, Riley SC, Calder AA. Natural antimicrobial production by the amnion. Am J Obstet Gynecol. 2007;196:255.e1–255.e6
  41. Meller D, Tseng SC. Conjunctival epithelial cell differentiation on amniotic membrane. Invest Ophthalmol Vis Sci. 1999;40:878–886
  42. Trelford Sauder M, Trelford JD, Matolo NM. Replacement of the peritoneum with amnion following pelvic exenteration. Surg Gynecol Obstet. 1977;145:699–701
  43. Hellebrekers BW, Trimbos-Kemper TC, Trimbos JB, Emeis JJ, Kooistra T. Use of fibrinolytic agents in the prevention of postoperative adhesion formation. Fertil Steril. 2000;74:203–212
  44. Bhatia M, Pereira M, Rana H, et al. The mechanism of cell interaction and response on decellularized human amniotic membrane: implications in wound healing. Wounds. 2007;19:207–217
  45. Dua HS, Gomes JA, King AJ, Maharajan VS. The amniotic membrane in ophthalmology. Surv Ophthalmol. 2004;49:51–77
  46. Koizumi NJ, Inatomi TJ, Sotozono CJ, Fullwood NJ, Quantock AJ, Kinoshita S. Growth factor mRNA and protein in preserved human amniotic membrane. Curr Eye Res. 2000;20:173–177
  47. Na BK, Hwang JH, Kim JC, et al. Analysis of human amniotic membrane components as proteinase inhibitors for development of therapeutic agent of recalcitrant keratitis. Trophoblast Res. 1999;13:459–466
  48. Hao Y, Ma DH, Hwang DG. Identification of antiangiogenic and anti-inflammatory proteins in human amniotic membrane. Cornea. 2000;19:348–352
  49. Capella-Allouc S, Morsad F, Rongières-Bertrand C, Taylor S, Fernandez H. Hysteroscopic treatment of severe Asherman's syndrome and subsequent fertility. Hum Reprod. 1999;14:1230–1233
  50. Yu D, Li TC, Xia E, Huang X, Liu Y, Peng X. Factors affecting reproductive outcome of hysteroscopic adhesiolysis for Asherman's syndrome. Fertil Steril. 2008;89:715–722
  51. Roy KK, Baruah J, Sharma JB, Kumar S, Kachawa G, Singh N. Reproductive outcome following hysteroscopic adhesiolysis in patients with infertility due to Asherman's syndrome. [published online ahead of print May 20, 2009] Arch Gynecol Obstet. 2010;281:355–361
  52. Yaffe H, Ron M, Polishuk WZ. Amenorrhea, hypomenorrhea, and uterine fibrosis. Am J Obstet Gynecol. 1978;130:599–601
  53. Deaton JL, Maier D, Andreoli J. Spontaneous uterine rupture during pregnancy after treatment of Asherman's syndrome. Am J Obstet Gynecol. 1989;160:1053–1054
  54. Friedman A, DeFazio J, DeCherney A. Severe obstetric complications after aggressive treatment of Asherman syndrome. Obstet Gynecol. 1986;67:864–867

 The authors have no commercial, proprietary, or financial interest in the products or companies described in this article.

PII: S1553-4650(10)00132-9

doi: 10.1016/j.jmig.2010.03.019

The Journal of Minimally Invasive Gynecology
Volume 17, Issue 5 , Pages 605-611 , September 2010

Article Tools

* Image Usage & Resolution